Japan Diabetes Care Devices Market Outlook to 2033 - Insulin Delivery and Glucose Monitoring

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Diabetes Care Devices Market, Japan, Revenue ($m), 2018-2033
3.2 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2023
3.3 Diabetes Care Devices Market, Japan, Category Contribution by Revenue ($m), 2023
3.4 Diabetes Care Devices Market, Japan, Revenue ($m), 2018-2033
3.5 Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
3.6 Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
3.7 Diabetes Care Devices Market, Japan, Company Share by Revenue ($m), 2023

4.1 Glucose Monitoring Market, Japan, Revenue ($m), 2018-2033
4.1.1 Blood Glucose Meters Market, Japan, Revenue ($m), by Segment, 2018-2033
4.2 Glucose Monitoring Market, Japan, Volume (Units), 2018-2033
4.2.1 Blood Glucose Meters Market, Japan, Volume (Units), by Segment, 2018-2033
4.3 Glucose Monitoring Market, Japan, Average Price ($) , 2018-2033
4.4 Glucose Monitoring Market, Japan, Distribution Share by Revenue ($m), 2023
4.5 Glucose Monitoring Market, Japan, Company Share by Revenue ($m), 2023

5.1 Insulin Delivery Market, Japan, Revenue Mix ($m), 2023
5.2 Insulin Delivery Market, Japan, Segment Contribution (%), 2023
5.3 Insulin Delivery Market, Japan, Revenue ($m), 2018-2033
5.3.1 Insulin Pens Market, Japan, Revenue ($m), by Segment, 2018-2033
5.3.2 Insulin Pumps Market, Japan, Revenue ($m), by Segment, 2018-2033
5.4 Insulin Delivery Market, Japan, Volume (Units), 2018-2033
5.4.1 Insulin Pens Market, Japan, Volume (Units), by Segment, 2018-2033
5.4.2 Insulin Pumps Market, Japan, Volume (Units), by Segment, 2018-2033
5.5 Insulin Delivery Market, Japan, Average Price ($) , 2018-2033
5.6 Insulin Delivery Market, Japan, Distribution Share by Revenue ($m), 2023
5.7 Insulin Delivery Market, Japan, Company Share by Revenue ($m), 2023

6.1 Abbott Laboratories
6.1.1 Company Overview
6.2 Eli Lilly and Co
6.2.1 Company Overview
6.3 Sanofi
6.3.1 Company Overview
6.4 Medtronic Plc
6.4.1 Company Overview
6.5 Novo Nordisk AS
6.5.1 Company Overview
6.6 DexCom Inc
6.6.1 Company Overview
6.7 F. Hoffmann-La Roche Ltd
6.7.1 Company Overview

8.1 Equity Offerings
8.1.1 Terumo Raises USD1.26 Billion in Private Placement of Shares
8.2 Private Equity
8.2.1 Consortium of Investor Invest USD5.44 Million in Provigate

9.1 Financial Announcements
9.1.1 Aug 26, 2024: Senzime Releases Interim Report January - June 2024
9.1.2 Apr 26, 2024: Nitto Denko Announces Consolidated Financial Statements for the Year Ended March 31, 2024
9.2 Government and Public Interest
9.2.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
9.3 Other Significant Developments
9.3.1 Oct 23, 2024: F. Hoffmann-La Roche Announces Third Quarter Sales 2024
9.3.2 Mar 12, 2024: TOHO Group Will Participate in “ReMed New Life for Used Medical Device.”, a Recycling Project for Used Pre-filled Injection Pens, for the First Time in Japan
9.4 Product News
9.4.1 Sep 04, 2024: PHC Launches LiCellMo Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies
9.4.2 Aug 30, 2024: PHC Unveils Prototype Of Licellgrow, New Cell Expansion System To Support Development Of Cell And Gene Therapy Products Manufacturing Process
9.4.3 Aug 01, 2024: Development of a Method to Predict Onset of Non-Alcoholic Fatty Liver Disease -Contributing to Preventive Healthcare for Lifestyle Diseases
9.4.4 Mar 12, 2024: TOHO Group Will Participate in “ReMed New Life for Used Medical Device.”, a Recycling Project for Used Pre-filled Injection Pens, for the First Time in Japan
9.5 Strategy And Business Planning
9.5.1 Feb 01, 2024: Strengthening the Direct Sales and Service System for Business Expansion in Italy
9.5.2 Jan 16, 2024: Orbis International and Nidek Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 The Publisher's Consulting
10.3 Contact the Publisher
10.4 Disclaimer

Table 1: Diabetes Care Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 2: Diabetes Care Devices Market, Japan, Category Contribution by Revenue ($m), 2023
Table 3: Diabetes Care Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 4: Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
Table 5: Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
Table 6: Diabetes Care Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2023
Table 7: Glucose Monitoring Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 8: Blood Glucose Meters Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 9: Glucose Monitoring Market, Japan, Volume (Units), 2018-2033
Table 10: Blood Glucose Meters Market, Japan, Volume (Units), 2018-2033
Table 11: Glucose Monitoring Market, Japan, Average Price ($), 2018-2033
Table 12: Glucose Monitoring Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023
Table 13: Glucose Monitoring Market, Japan, Company Share by Revenue ($m), USD Constant, 2023
Table 14: Insulin Delivery Market, Japan, Segment Contribution (%), 2023
Table 15: Insulin Delivery Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 16: Insulin Pens Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 17: Insulin Pumps Market, Japan, Revenue ($m), USD Constant, 2018-2033
Table 18: Insulin Delivery Market, Japan, Volume (Units), 2018-2033
Table 19: Insulin Pens Market, Japan, Volume (Units), 2018-2033
Table 20: Insulin Pumps Market, Japan, Volume (Units), 2018-2033
Table 21: Insulin Delivery Market, Japan, Average Price ($), 2018-2033
Table 22: Insulin Delivery Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023
Table 23: Insulin Delivery Market, Japan, Company Share by Revenue ($m), USD Constant, 2023
Table 24: Diabetes Care Devices Market Pipeline Products
Table 25: Terumo Raises USD1.26 Billion in Private Placement of Shares
Table 26: Consortium of Investor Invest USD5.44 Million in Provigate

Figure 1: Diabetes Care Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 2: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2023
Figure 3: Diabetes Care Devices Market, Japan, Category Contribution (%), 2023
Figure 4: Diabetes Care Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 5: Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
Figure 6: Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033
Figure 7: Diabetes Care Devices Market, Japan, Company Share (%) 2023
Figure 8: Glucose Monitoring Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 9: Blood Glucose Meters Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 10: Glucose Monitoring Market, Japan, Volume (Units), 2018-2033
Figure 11: Blood Glucose Meters Market, Japan, Volume (Units), 2018-2033
Figure 12: Glucose Monitoring Market, Japan, Company Share (%) 2023
Figure 13: Insulin Delivery Market, Japan, Revenue Mix ($m), 2023
Figure 14: Insulin Delivery Market, Japan, Segment Contribution (%), 2023
Figure 15: Insulin Delivery Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 16: Insulin Pens Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 17: Insulin Pumps Market, Japan, Revenue ($m), USD Constant, 2018-2033
Figure 18: Insulin Delivery Market, Japan, Volume (Units), 2018-2033
Figure 19: Insulin Pens Market, Japan, Volume (Units), 2018-2033
Figure 20: Insulin Pumps Market, Japan, Volume (Units), 2018-2033
Figure 21: Insulin Delivery Market, Japan, Company Share (%) 2023